Trademark: 79095162
Status Date
Tuesday, March 16, 2021
Registration Number
4239666
Registration Date
Tuesday, November 13, 2012
Filing Date
Wednesday, March 16, 2011
Published for Opposition
Tuesday, August 28, 2012
Cancellation Date
Tuesday, March 16, 2021
1 Chemicals for use in the cryo-preservation of cells, differentiated cells, stem cells and cells derived therefrom; chemicals for use in scientific research relating to the isolation, insertion, positioning and maintenance of differentiated cells, stem cells and cells derived therefrom
5 Pharmaceutical and veterinary preparations for orthopaedic, ophthalmic, neurologic, oncologic and immunologic use; pharmaceutical and veterinary preparations for use in regenerative medicine for the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; pharmaceuticals and veterinary preparations for the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; chemical preparations adapted for pharmaceutical, medical and veterinary use for treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; differentiated cells, stem cells and cells derived there from for medical, veterinary or clinical use; stem cells for cellular therapeutics for medical, veterinary or clinical use; cryo-preserved stem cells; cell-derived preparations for medical, veterinary or clinical use; platelet rich plasma; growth factor preparations for injection for the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; surgical implants comprising of living tissue, namely, bones and soft tissue, allogeneic bone graft material; medical plasters, wound dressings, medical dressings
10 Surgical, medical, and veterinary apparatus and instruments for orthopaedic, ophthalmic, neurologic, oncologic and immunologic use; medical and veterinary apparatus and instruments for cryo-preservation of stem cells; surgical, medical and veterinary apparatus and instruments for use in the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage and injuries, tendon and ligament damage and injuries, musculoskeletal damage and injuries; surgical, medical and veterinary apparatus for use in the isolation, insertion, positioning and maintenance, including storage, of differentiated cells, stem cells and cells derived therefrom, cell-derived products and regenerative technology; artificial allogeneic bone graft material; ceramic bone graft substitute
42 Scientific research and development services and design services for others in the field of orthopaedics, ophthalmics, neurology, oncology, immunology, regenerative medicine, differentiated cells, stem cells and cells derived there from, cellular and cell-derived therapeutics; veterinary and medical research services; scientific and industrial research in the field of orthopaedics, ophthalmics, neurology, oncology, immunology, regenerative medicine, differentiated cells, stem cells and cells derived there from, cellular and cell-derived therapeutics; scientific research and development services relating to regenerative medicine and technologies; scientific research and development relating to differentiated cells, stem cells and cells derived there from and cell-derived therapeutics; scientific research and development relating to cellular and cell-derived therapeutics; providing scientific and medical research information on pharmaceutical, medical and veterinary products and services through an on-line computer network
44 Medical services; veterinary services: medical and veterinary services relating to the isolation,insertion, positioning, maintenance, and storage of differentiated cells, stem cells and cells derived therefrom, and cell-derived preparations, platelet rich plasma and growth factor injections; medical and veterinary consultancy services
Color is not claimed as a feature of the mark.
VETERINARY CELL
Nov 7, 2021
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Nov 7, 2021
Death Of International Registration
Feb 5, 2021
New Representative At Ib Received
Jan 5, 2019
Total Invalidation Processed By The Ib
Dec 2, 2018
Total Invalidation Of Reg Ext Protection Sent To Ib
Dec 2, 2018
Invalidation Processed
Nov 20, 2018
Total Invalidation Of Reg Ext Protection Created
Mar 20, 2018
Cancelled Section 18-Total
Mar 20, 2018
Cancellation Terminated No. 999999
Mar 20, 2018
Cancellation Granted No. 999999
Oct 31, 2017
Cancellation Instituted No. 999999
May 31, 2015
Change Of Owner Received From Ib
Jul 31, 2014
New Representative At Ib Received
Mar 10, 2013
Final Decision Transaction Processed By Ib
Feb 15, 2013
Final Disposition Notice Sent To Ib
Feb 15, 2013
Final Disposition Processed
Feb 13, 2013
Final Disposition Notice Created, To Be Sent To Ib
Nov 13, 2012
Registered-Principal Register
Sep 29, 2012
Notification Processed By Ib
Aug 28, 2012
Published For Opposition
Aug 8, 2012
Notification Of Possible Opposition Sent To Ib
Aug 8, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 8, 2012
Notice Of Publication
Jul 25, 2012
Law Office Publication Review Completed
Jul 24, 2012
Approved For Pub - Principal Register
Jul 11, 2012
Examiners Amendment Mailed
Jul 11, 2012
Examiner's Amendment Entered
Jul 11, 2012
Examiners Amendment -Written
Jun 30, 2012
Amendment From Applicant Entered
Jun 30, 2012
Correspondence Received In Law Office
Jun 20, 2012
Paper Received
Jan 11, 2012
Final Refusal Mailed
Jan 10, 2012
Final Refusal Written
Jan 5, 2012
Amendment From Applicant Entered
Jan 5, 2012
Correspondence Received In Law Office
Dec 20, 2011
Assigned To Lie
Dec 16, 2011
Paper Received
Aug 6, 2011
Refusal Processed By Ib
Jun 17, 2011
Non-Final Action Mailed - Refusal Sent To Ib
Jun 17, 2011
Refusal Processed By Mpu
Jun 17, 2011
Non-Final Action (Ib Refusal) Prepared For Review
Jun 16, 2011
Non-Final Action Written
Jun 15, 2011
Assigned To Examiner
Apr 19, 2011
Application Filing Receipt Mailed
Apr 15, 2011
New Application Office Supplied Data Entered In Tram
Apr 14, 2011
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
